Topics:
Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Yale • Triple negative • NCI-CCC Breast Tumor Board Question • Breast Cancer, Metastatic
Do you approach treatment any differently for a patient with prior early-stage hormone receptor positive breast cancer who experiences metastatic triple negative recurrence?
How does one's history of HR+ breast cancer influence treatment decision?
Patient has no new obvious primary.